Mediware Merger Alert: Briscoe Law Firm And Powers Taylor, LLP Investigate Sale Of Mediware Information Systems To Private Equity Firm
Former United States Securities and Exchange Commission attorney
Briscoe and the securities litigation firm of
Taylor, LLP are investigating the sale of Mediware Information
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Mediware Information Systems, Inc. (“Mediware”)(NasdaqCM: MEDW) to private equity firm Thoma Bravo, LLC for shareholders. The proposed Mediware merger is valued at approximately $195 million, and Mediware shareholders will receive only $22.00 in cash for each share of Mediware stock owned. There is no cost or fee for affected Mediware investors to join the action. Thus, if you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at firstname.lastname@example.org, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com. The Mediware merger investigation centers on whether Mediware shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Mediware stock, and whether Mediware’s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. “Our investigation is aimed at ensuring that the transaction is fair to all Mediware shareholders and that they are obtaining the highest possible price for their shares,” said shareholder rights attorney Willie Briscoe. The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters. Powers Taylor, LLP is a boutique Dallas litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.